Alessandra Ricco

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial

Tiziano Barbui, Alessandro M. Vannucchi, Valerio De Stefano et al. · The Lancet Haematology · 2021 · 125 citations · Full text

Polycythaemia Vera, Hematology, Low-pv Study +2

A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia

Bianca Rocca, Alberto Tosetto, Silvia Betti et al. · Blood · 2020 · 100 citations · Full text

Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study

Fabio Efficace, Gianluca Gaïdano, Massimo Breccia et al. · The Lancet Oncology · 2015 · 84 citations

Hematological Malignancy, Prognostic Evaluation, Fatigue Management +7

Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases

Emanuela Sant’Antonio, Paola Guglielmelli, Lisa Pieri et al. · American Journal of Hematology · 2019 · 67 citations · Full text

Retrospective Study, Thrombosis, Hematological Malignancy +14

Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera

Tiziano Barbui, Alessandro M. Vannucchi, Valerio De Stefano et al. · NEJM Evidence · 2023 · 44 citations · Full text